Published Date: 08 Mar 2023
People with hypertension (high blood pressure in the arteries that supply the lungs, also known as PAH) have up to a two-fold reduction in pulmonary vascular resistance (PVR) when taking PAH.
Read Full NewsFor patients with locally advanced esophageal cancer, front-loading immunotherapy with induction chemo and chemoradiotherapy, without maintenance immunotherapy, may improve outcomes.
Posttreatment ctDNA positivity correlates with worse relapse-free survival and earlier recurrence in patients with locally advanced cervical cancer, real-world data show.
There’s now a hint that GLP-1 receptor agonists might prevent hysterectomies in endometrial intraepithelial neoplasia/early-stage endometrial cancer, but prospective trials are needed to confirm it.
1.
Making informed decisions and managing regret after prostate cancer treatment
2.
Analysis of 2021 data shows new cancer diagnoses did not rebound as expected following pandemic
3.
Chemicals in Sewage Sludge Fertilizer Pose Cancer Risk, EPA Says
4.
Hypnotherapy may offer real benefits for cancer patient care
5.
Study Finds Actionable Mutations in Brain Mets of Breast Cancer Patients
1.
How to Prevent Tumor Lysis Syndrome in Cancer Patients
2.
Revolutionizing Oncology: AI in Radiology, Machine Learning in Pathology, and Deep Learning for Cancer Detection
3.
Oncology Drug Trends 2025: FDA Approvals, Immuno-Oncology, and Clinical Trial Insights
4.
Oncolytic Adenoviruses Targeting PD-L1: Advancing Cancer Immunotherapy and Tumor Control
5.
Neoepitope Vaccines in Oncology: Precision, Sequencing, and Immunotherapy Frontiers
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
An Eagles View - Evidence-based discussion on Iron Deficiency Anemia
2.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion III
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part VI
4.
Navigating the Complexities of Ph Negative ALL - Part XII
5.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part I
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation